Enliven Therapeutics - 54 Year Dividend History | ELVN
Historical dividend payout and yield for Enliven Therapeutics (ELVN) since 1971. The current TTM dividend payout for Enliven Therapeutics (ELVN) as of January 31, 2025 is $0.00. The current dividend yield for Enliven Therapeutics as of January 31, 2025 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$1.019B |
$0.000B |
|
Enliven Therapeutics Inc. is a clinical-stage precision oncology company focused on the discovery and development of small molecule kinase inhibitors. The Company's lead product candidate includes ELVN-001 and ELVN-002. Enliven Therapeutics Inc., formerly known as Imara Inc., is based in Boulder, CO.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
